Hydroxychloroquine News and Research

RSS

New clinical trial to test two drugs for prophylactic treatment of COVID-19 contact persons

With the stepwise easing of measures in Switzerland, it is pivotal to monitor for any new COVID-19 outbreaks and to contain them in a timely and effective manner.

23 Apr 2020

Is hydroxychloroquine effective against COVID-19?

Following the emergence of a novel coronavirus in Wuhan, China, in the last month of 2019, it has spread globally to produce the first pandemic of the 21st century. The virus, called severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has already affected over 2.5 million and killed more than 177,000 people as of April 22, 2020.

22 Apr 2020

Penn Medicine launches convalescent plasma therapy trial for COVID-19 patients

Convalescent plasma therapy for COVID-19 patients -- an experimental approach of giving a transfusion of plasma collected from a donor who has recovered from COVID-19 to a patient with an active infection -- is the focus of a new two-part research initiative at Penn Medicine.

20 Apr 2020

Hydroxychloroquine and azithromycin treatment in 80 COVID-19 patients: short-term outcomes

The COVID-19 pandemic is still spreading around the world and affecting nearly 2.4 million people, with over 164,000 dead so far. With neither vaccine nor proven therapeutic drug being available so far, the need of the hour is for effective treatment. Now, a new study reports the potential usefulness of a combination of hydroxychloroquine and azithromycin as a treatment in mild cases of COVID-19 infection and urges the need for further evaluation and widespread use if its findings are confirmed.

19 Apr 2020

100th COVID-19 patient discharged from St. Luke’s Anderson Campus

St. Luke’s Anderson Campus discharged its 100th COVID-19 patient Wednesday. The Anderson Campus in Bethlehem Township is one of the Network’s 11 hospitals.

17 Apr 2020

Cost of ‘repurposing’ existing drugs to treat COVID-19

The paper looks at repurposed drugs that might demonstrate efficacy against COVID-19, and if they could be manufactured profitably at very low costs to ensure affordable access to vital treatments for COVID-19 at low prices globally.

13 Apr 2020

Intermountain Healthcare and University of Utah Health launch two COVID-19 clinical trials

Researchers from Intermountain Healthcare and University of Utah Health in Salt Lake City have launched two vital clinical trials to test the effectiveness and safety of two drugs - hydroxychloroquine and azithromycin - to treat patients with COVID-19.

13 Apr 2020

Novel clinical trial fast tracks testing of COVID-19 therapies

A novel clinical trial developed by researchers at the University of Pittsburgh School of Medicine launched today at UPMC to address one of the most important debates during the COVID-19 pandemic:

9 Apr 2020

University of Utah Health, Intermountain Healthcare launch two clinical trials to treat COVID-19 patients

Researchers from Intermountain Healthcare and University of Utah Health in Salt Lake City have launched two vital clinical trials to test the effectiveness and safety of two drugs -hydroxychloroquine (HCQ) and azithromycin - to treat patients with COVID-19 (infection with the novel coronavirus).

9 Apr 2020

Clinical trial to investigate effectiveness of antimalarial drugs for COVID-19 treatment

Washington University School of Medicine in St. Louis is launching a clinical trial for patients hospitalized with COVID-19 at Barnes-Jewish Hospital.

9 Apr 2020

Potential harms associated with some drugs used for treating COVID-19 patients

Chloroquine, hydroxychloroquine and azithromycin are being used to treat and prevent COVID-19 despite weak evidence for effectiveness, and physicians and patients should be aware of the drugs' potentially serious adverse events, states a review in CMAJ.

8 Apr 2020

Penn-led trial to evaluate the effectiveness of HCQ in combating COVID-19 pandemic

A new trial led by the Perelman School of Medicine at the University of Pennsylvania will evaluate whether the drug hydroxychloroquine can benefit people infected with COVID-19, as well as whether taking the drug preventatively may help people avoid infection altogether.

6 Apr 2020

ATS releases new guidance to help clinicians manage COVID-19 patients

An American Thoracic Society-led international task force has released a guidance document to help clinicians manage COVID-19 patients in the face of a worldwide pandemic and minimal empirical evidence to guide treatment.

6 Apr 2020

‘You pray that you got the drug.’ Ailing couple gambles on trial for COVID-19 cure

For 10 days last month, they lay in side-by-side isolation units in a Seattle-area hospital, tethered to oxygen and struggling to breathe as the coronavirus ravaged their lungs.

6 Apr 2020

Who should be taking antimalarial drugs as treatment against COVID-19?

Researchers provide a guideline regarding who should be actually taking antimalarial drugs as prophylaxis to prevent getting COVID-19. They say health professionals who are being exposed to COVID-19 positive patients and those who test positive but are asymptomatic should be taking drugs such as Chloroquine and Hydroxychloroquine. They explain that these populations remain most in need, and because of limited supply, these individuals need to be prioritized.

2 Apr 2020

Drugs considered for COVID-19 can increase risk for dangerous arrhythmias

As some consider treating coronavirus patients with a combination of the malaria drug hydroxychloroquine and the antibiotic azithromycin, cardiologists are advising caution because both medications can increase the risk for dangerous abnormal heart rhythms.

2 Apr 2020

Duke to lead PCORI-funded study of COVID-19 prevention in healthcare workers

The Patient-Centered Outcomes Research Institute has funded up to $50 million to evaluate hydroxychloroquine (HCQ) as a preventive drug for the novel coronavirus.

1 Apr 2020

PCORI funds $50 million to study HCQ's effectiveness in preventing COVID-19 in healthcare workers

The Patient-Centered Outcomes Research Institute Board of Governors today approved up to $50 million to fund a registry and randomized clinical trial of the effectiveness of hydroxychloroquine in preventing COVID-19 infections in U.S. healthcare workers.

1 Apr 2020

FDA to trial malaria drugs Chloroquine and Hydroxychloroquine for COVID-19

The U.S. Food and Drug Administration (FDA) this week provided the necessary authorization for clinical trials of chloroquine and hydroxychloroquine for the treatment of the novel coronavirus. These two drugs have been claimed by President Donald Trump to be a potential treatment for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection, which causes COVID-19 disease. To date, there has been no conclusive proof regarding the safety and efficacy of these drugs in COVID-19 cases, say officials.

31 Mar 2020

Will 'old faithful' tuberculosis BCG vaccine work against COVID?

All over the world, except in China, the place where it all began, the COVID-19 pandemic is making its relentless way through the population. So far, it has caused nearly 34,000 deaths – and the situation in the US is still worsening with over 142,000 cases and 2,489 deaths. In Australia, the number of cases has climbed to 4,093, with 16 fatalities.

29 Mar 2020

Hydroxychloroquine News and Research

New clinical trial to test two drugs for prophylactic treatment of COVID-19 contact persons

Is hydroxychloroquine effective against COVID-19?

Penn Medicine launches convalescent plasma therapy trial for COVID-19 patients

Hydroxychloroquine and azithromycin treatment in 80 COVID-19 patients: short-term outcomes

100th COVID-19 patient discharged from St. Luke’s Anderson Campus

Cost of ‘repurposing’ existing drugs to treat COVID-19

Intermountain Healthcare and University of Utah Health launch two COVID-19 clinical trials

Novel clinical trial fast tracks testing of COVID-19 therapies

University of Utah Health, Intermountain Healthcare launch two clinical trials to treat COVID-19 patients

Clinical trial to investigate effectiveness of antimalarial drugs for COVID-19 treatment

Potential harms associated with some drugs used for treating COVID-19 patients

Penn-led trial to evaluate the effectiveness of HCQ in combating COVID-19 pandemic

ATS releases new guidance to help clinicians manage COVID-19 patients

‘You pray that you got the drug.’ Ailing couple gambles on trial for COVID-19 cure

Who should be taking antimalarial drugs as treatment against COVID-19?

Drugs considered for COVID-19 can increase risk for dangerous arrhythmias

Duke to lead PCORI-funded study of COVID-19 prevention in healthcare workers

PCORI funds $50 million to study HCQ's effectiveness in preventing COVID-19 in healthcare workers

FDA to trial malaria drugs Chloroquine and Hydroxychloroquine for COVID-19

Will 'old faithful' tuberculosis BCG vaccine work against COVID?

Deciphering the Microbiome with The Microsetta Initiative

Leveraging the power of automation to boost research

Automating research - solutions and best practices

Latest News